Histological and immunohistochemical findings after laser in situ keratomileusis in human corneas

Journal of Cataract and Refractive Surgery

Volumn 29, Issue 4, 2003, Pages 808-820

  Philipp, Wolfgang E ^a   Speicher, Lilly ^a   Göttinger, Wolfgang ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DERMATAN SULFATE; SCATTER FACTOR;

ADULT; ARTICLE; ASTIGMATISM; AUSTRIA; BIOMECHANICS; CASE REPORT; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA STROMA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERMETROPIA; IMMUNOHISTOCHEMISTRY; KERATOMILEUSIS; MALE; MYOPIA; PENETRATING KERATOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCAR FORMATION; TENSILE STRENGTH; THICKNESS; WOUND HEALING;

EID: 0037388104     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(02)01611-5     Document Type: Article

References (79)

1. Pallikaris IG, Papatzanaki ME, et al. Laser in situ keratomileusis. Lasers Surg Med 1990; 10:463-468
2. Rosen ES. LASIK mania [editorial]. J Cataract Refract Surg 2000; 26:303-304
3. Farah SG, Azar DT, Gurdal C, Wong J. Laser in situ keratomileusis: literature review of a developing technique. J Cataract Refract Surg 1998; 24:989-1006
4. Choi RY, Wilson SE. Hyperopic laser in situ keratomileusis; primary and secondary treatments are safe and effective. Cornea 2001; 20:388-393
5. Arbelaez MC, Knorz MC. Laser in situ keratomileusis for hyperopia and hyperopic astigmatism. J Refract Surg 1999; 15:406-414
6. Seiler T. Iatrogenic keratectasia: academic anxiety or serious risk? [editoral] J Cataract Refract Surg 1999; 25:1307-1308
7. Gimbel HV, Penno EEA, van Westenbrugge JA, et al. Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis cases. Ophthalmology 1998; 105:1839-1847; discussion by TE Clinch, 1847-1848
8. Alió JL, Artola A, Claramonte PJ, et al. Complications of photorefractive keratectomy for myopia: two year follow-up of 3000 cases. J Cataract Refract Surg 1998; 24:619-626
9. Vesaluoma M, Pérez-Santonja J, Petroll WM, et al. Corneal stromal changes induced by myopic LASIK. Invest Ophthalmol Vis Sci 2000; 41:369-376
10. Steinert RF, McColgin AZ, White A, Horsburgh GM. Diffuse interface keratitis after laser in situ keratomileusis (LASIK): a nonspecific syndrome. Am J Ophthalmol 2000; 129:380-381
11. Tham VM-B, Maloney RK. Microkeratome complications of laser in situ keratomileusis. Ophthalmology 2000; 107:920-924
12. Quiros PA, Chuck RS, Smith RE, et al. Infectious ulcerative keratitis after laser in situ keratomileusis. Arch Ophthalmol 1999; 117:1423-1427
13. Hori Y, Watanabe H, Maeda N, et al. Medical treatment of operative corneal perforation caused by laser in situ keratomileusis. Arch Ophthalmol 1999; 117:1422-1423
14. Wright JD Jr, Neubaur CC, Stevens G Jr. Epithelial in-growth in a corneal graft treated by laser in situ keratomileusis: light and electron microscopy. J Cataract Refract Surg 2000; 26:49-55
15. Walker MB, Wilson SE. Incidence and prevention of epithelial growth within the interface after laser in situ keratomileusis. Cornea 2000; 19:170-173
16. Kaufman SC, Maitchouk DY, Chiou AGY, Beuerman RW. Interface inflammation after laser in situ keratomileusis; sands of the Sahara syndrome. J Cataract Refract Surg 1998; 24:1589-1593
17. Smith RJ, Maloney RK. Diffuse lamellar keratitis; a new syndrome in lamellar refractive surgery. Ophthalmology 1998; 105:1721-1726
18. Seiler T, Quurke AW. Iatrogenic keratectasia after LASIK in a case of forme fruste keratoconus. J Cataract Refract Surg 1998; 24:1007-1009
19. Speicher L, Göttinger W. Progressive Keratektasie nach Laser-in-Situ-Keratomileusis (LASIK). Klin Monatsbl Augenheilkd 1998; 213:247-251; corrigendum, 372
20. McLeod SD, Kisla TA, Caro NC, McMahon TT. Iatrogenic keratoconus: corneal ectasia following laser in situ keratomileusis for myopia. Arch Ophthalmol 2000; 118:282-284
21. Joo C-K, Kim T-G. Corneal ectasia detected after laser in situ keratomileusis for correction of less than - 12 diopters of myopia. J Cataract Refract Surg 2000; 26:292-295
22. Amoils SP, Deist MB, Gous P, Amoils PM. Iatrogenic keratectasia after laser in situ keratomileusis for less than -4.0 to -7.0 diopters of myopia. J Cataract Refract Surg 2000; 26:967-977
23. Seiler T, Koufala K, Richter G. Iatrogenic keratectasia after laser in situ keratomileusis. J Refract Surg 1998; 14:312-317
24. Geggel HS, Talley AR. Delayed onset keratectasia following laser in situ keratomileusis. J Cataract Refract Surg 1999; 25:582-586
25. Argento C, Cosentino MJ, Tytiun A, et al. Corneal ectasia after laser in situ keratomileusis. J Cataract Refract Surg 2001; 27:1440-1448
26. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res 1999; 18:293-309
27. Schultz G, Khaw PT, Oxford K, et al. Growth factors and ocular wound healing. Eye 1994; 8:184-187
28. Li D-Q, Tseng SCG. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-α, platelet-derived growth factor B, and interleukin-β. Invest Ophthalmol Vis Sci 1996; 37:2068-2080
29. Bennett NT, Schultz GS. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am J Surg 1993; 166:74-81
30. Kaji Y, Mita T, Obata H, et al. Expression of transforming growth factor β superfamily and their receptors in the corneal stromal wound healing process after excimer laser keratectomy [letter]. Br J Ophthalmol 1998; 82:462-463
31. Kim W-J, Mohan RR, Mohan RR, Wilson SE. Effect of PDGF, IL-1α, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Invest Ophthalmol Vis Sci 1999; 40:1364-1372
32. Andresen JL, Ehlers N. Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta. Curr Eye Res 1998; 17:79-87
33. Hoppenreijs VPT, Pels E, Vrensen GFJM, et al. Platelet-derived growth factor: receptor expression in corneas and effects on corneal cells. Invest Ophthalmol Vis Sci 1993; 34:637-649
34. Andresen JL, Ledet T, Ehlers N. Keratocyte migration and peptide growth factors: the effect of PDGF, bFGF, EGF, IGF-I, aFGF and TGF-β on human keratocyte migration in a collagen gel. Curr Eye Res 1997; 16:605-613
35. Jester JV, Huang J, Barry-Lane PA, et al. Transforming growth factorβ-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest Ophthalmol Vis Sci 1999; 40:1959-1967
36. Hoppenreijs VPT, Pels E, Vrensen GFJM, Treffers WF. Effects of platelet-derived growth factor on endothelial wound healing of human corneas. Invest Ophthalmol Vis Sci 1994; 35:150-161
37. Mita T, Yamashita H, Kaji Y, et al. Effects of transforming growth factor β on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy. Graefes Arch Clin Exp Ophthalmol 1998; 236:834-843
38. Weng J, Mohan RR, Li Q, Wilson SE. IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 β expression in the cornea. Cornea 1997; 16:465-471
39. Li DQ, Tseng SCG. Differential regulation of keratinocyte growth factor and hepatocyte growth factor/scatter factor by different cytokines in human corneal and limbal fibroblasts. J Cell Physiol 1997; 172:361-372
40. Wilson SE, Chen L, Mohan RR, et al. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res 1999; 68:377-397
41. Bonnard C, Papermaster DS, Kraehenbuhl JP. The streptavidin-biotin bridge technique: application in light and electron microscope immunocytochemistry. In: Polak JM, Varndell IM, eds, Immunolabelling for Electron Microscopy. Amsterdam, Elsevier, 1984; 95-111
42. Wachtlin J, Langenbeck K, Schründer S, et al. Immunohistology of corneal wound healing after photorefractive keratectomy and laser in situ keratomileusis. J Refract Surg 1999; 15:451-458
43. Park CK, Kim JH. Comparison of wound healing after photorefractive keratectomy and laser in situ keratomileusis in rabbits. J Cataract Refract Surg 1999; 25:842-850
44. Amm M, Wetzel W, Winter M, et al. Histopathological comparison of photorefractive keratectomy and laser in situ keratomileusis in rabbits. J Refract Surg 1996; 12:758-766
45. Anderson JA, Binder PS, Rock ME, Vrabec MP. Human excimer laser keratectomy; immunohistochemical analysis of healing. Arch Ophthalmol 1996; 114:54-60
46. Goodman GL, Trokel SL, Stark WJ, et al. Corneal healing following laser refractive keratectomy. Arch Ophthalmol 1989; 107:1799-1803
47. Fagerholm P. Wound healing after photorefractive keratectomy. J Cataract Refract Surg 2000; 26:432-447
48. Malley DS, Steinert RF, Puliafito CA, Dobi ET. Immunofluorescence study of corneal wound healing after excimer laser anterior keratectomy in the monkey eye. Arch Ophthalmol 1990; 108:1316-1322
49. Hanna KD, Pouliquen Y, Waring GO III, et al. Corneal stromal wound healing in rabbits after 193-nm excimer laser surface ablation. Arch Ophthalmol 1989; 107:895-901
50. Gaster RN, Binder PS, Coalwell K, et al. Corneal surface ablation by 193 nm excimer laser and wound healing in rabbits. Invest Ophthalmol Vis Sci 1989; 30:90-98
51. Lohmann CP, Patmore A, O'Brart D, et al. Regression and wound healing after excimer laser PRK: a histopathological study on human corneas. Eur J Ophthalmol 1997; 7:130-138
52. Newsome DA, Foidart J-M, Hassell JR, et al. Detection of specific collagen types in normal and keratoconus corneas. Invest Ophthalmol Vis Sci 1981; 20:738-750
53. Nakayasu K, Tanaka M, Konomi H, Hayashi T. Distribution of types I, II, III, IV and V collagen in normal and keratoconus corneas. Ophthalmic Res 1986; 18:1-10
54. Zimmermann DR, Trueb B, Winterhalter KH, et al. Type VI collagen is a major component of the human cornea. FEBS Lett 1986; 197:55-58
55. Zimmermann DR, Fischer RW, Winterhalter KH, et al. Comparative studies of collagens in normal and keratoconus corneas. Exp Eye Res 1988; 46:431-442
56. Delaigue O, Arbeille B, Rossazza C, et al. Quantitative analysis of immunogold labellings of collagen types I, III, IV and VI in healthy and pathological human corneas. Graefes Arch Clin Exp Ophthalmol 1995; 233:331-338
57. SundarRaj N, Geiss MJ III, Fantes F, et al. Healing of excimer laser ablated monkey corneas; an immunohistochemical evaluation. Arch Ophthalmol 1990; 108:1604-1610
58. Hassell JR, Newsome DA, Hascall VC. Characterization and biosynthesis of proteoglycans of corneal stroma from rhesus monkey. J Biol Chem 1979; 254:12346-12354
59. Hassell JR, Schrecengost PK, Rada JA, et al. Biosyntheses of stromal matrix proteoglycans and basement membrane components by human corneal fibroblasts. Invest Ophthalmol Sci 1992; 33:547-557
60. Funderburgh JL, Cintron C, Covington HI, Conrad GW. Immunoanalysis of keratan sulfate proteoglycan from corneal scars. Invest Ophthalmol Vis 1988; 29:1116-1124
61. Cintron C, Covington HI, Kublin CL. Morphologic analyses of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci 1990; 31:1789-1798
62. Cintron C, Gregory JD, Damle SP, Kublin CL. Biochemical analyses of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci 1990; 31:1975-1981
63. Sawaguchi S, Yue BYJT, Chang I, et al. Proteoglycan molecules in keratoconus corneas. Invest Ophthalmol Vis Sci 1991; 32:1846-1853
64. Funderburgh JL, Chandler JW. Proteoglycans of rabbit corneas with nonperforating wounds. Invest Ophthalmol Vis Sci 1989; 30:435-442
65. Wilson SE, He Y-G, Weng J, et al. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res 1996; 62:325-327
66. Helena MC, Baerveldt F, Kim W-J, Wilson SE. Keratocyte apoptosis after corneal surgery. Invest Ophthalmol Vis Sci 1998; 39:276-283
67. Mohan RR, Liang Q, Kim W-J, et al. Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp Eye Res 1997; 65:575-589
68. Wilson SE, Kim W-J. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci 1998; 39:220-226
69. Lin RT, Maloney RK. Flap complications associated with lamellar refractive surgery. Am J Ophthalmol 1999; 127:129-136
70. Lafond G, Bazin R, Lajoie C. Bilateral severe keratoconus after laser in situ keratomileusis in a patient with forme fruste keratoconus. J Cataract Refract Surg 2001; 27:1115-1118
71. Aron Rosa DS, Febbraro JL. Laser in situ keratomileusis for hyperopia. J Refract Surg 1999; 15:212-215
72. Reviglio VE, Luna JD, Rodríguez ML, et al. Laser in situ keratomileusis using the LaserSight 200 laser: results of 950 consecutive cases. J Cataract Refract Surg 1999; 25:1062-1068
73. Argento CJ, Cosentino MJ. Comparision of optical zones in hyperopic laser in situ keratomileusis: 5.9 mm versus smaller optical zones. J Cataract Refract Surg 2000; 26:1137-1146
74. Majmudar PA, Forstot SL, Dennis RF, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000; 107:89-94
75. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992; 99:1647-1654
76. Azar DT, Jain S. Topical MMC for subepithelial fibrosis after refractive corneal surgery [letter]. Ophthalmology 2001; 108:239-240
77. Rashad KM. Laser in situ keratomileusis for the correction of hyperopia from + 1.25 to + 5.00 diopters with the Keracor 117C laser. J Refract Surg 2001; 17:113-122
78. Ibrahim O. Laser in situ keratomileusis for hyperopia and hyperopic astigmatism. J Refract Surg 1998; 14:S179-S182
79. Ditzen K, Huschka H, Pieger S. Laser in situ keratomileusis for hyperopia. J Cataract Refract Surg 1998; 24:42-47